Difficulty Swallowing: Labs, Diagnosis, and Next Steps

What Dysphagia Actually Means

Dysphagia is the medical term for difficulty swallowing, and it is not a single disease. It is a symptom that points toward dozens of possible underlying conditions. The clinical approach starts by determining whether the problem originates in the throat (oropharyngeal dysphagia) or the esophagus (esophageal dysphagia), because the diagnostic pathway and treatment differ sharply between these two categories.

Oropharyngeal dysphagia typically involves trouble initiating a swallow. Patients describe food "sticking" at the throat level, coughing or choking during meals, or nasal regurgitation. Neurological conditions account for a large share of these cases. Stroke is the leading cause, with dysphagia occurring in 37% to 78% of acute stroke patients depending on the screening method used [1]. Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis also frequently produce oropharyngeal symptoms.

Esophageal dysphagia, by contrast, presents as a sensation of food lodging behind the breastbone. The causes here tend to be structural (strictures, rings, tumors) or motility-related (achalasia, esophageal spasm). A 2018 population-based study in Gastroenterology estimated that esophageal dysphagia affects approximately 10% of adults over 50 in the United States [2]. Distinguishing these two categories is the single most important step in the workup.

Why You Should Not Ignore Swallowing Problems

Persistent dysphagia carries real risks. This is not a symptom to wait out. Aspiration pneumonia, malnutrition, dehydration, and undiagnosed malignancy all become more likely when swallowing dysfunction goes unaddressed for months or years.

The American Gastroenterological Association (AGA) recommends that any patient with progressive solid-food dysphagia undergo upper endoscopy to exclude malignancy and structural lesions [3]. "Progressive dysphagia for solids, particularly when accompanied by weight loss, should prompt urgent endoscopic evaluation," states the AGA's technical review on management of oropharyngeal and esophageal dysphagia. Red-flag symptoms that warrant same-week or urgent referral include:

• Dysphagia progressing from solids to liquids over weeks
• Unintentional weight loss exceeding 5% of body weight
• Complete food impaction requiring emergency removal
• Odynophagia (pain on swallowing) combined with dysphagia
• New-onset dysphagia in a patient over age 50 with a smoking history

Even without red flags, dysphagia lasting more than two to four weeks deserves medical evaluation. Early diagnosis changes outcomes significantly for conditions like eosinophilic esophagitis and achalasia.

The Clinical Swallowing Evaluation

Before ordering labs or imaging, most clinicians begin with a structured bedside or clinical swallowing evaluation (CSE). A speech-language pathologist (SLP) observes the patient swallowing liquids and solids of varying consistency, assessing oral motor function, laryngeal elevation, voice quality after swallowing, and signs of aspiration such as coughing or wet vocal quality.

The CSE takes 20 to 40 minutes. It cannot visualize the pharynx or esophagus directly, but it identifies patients who need instrumental assessment and determines safe diet textures in the interim. A systematic review in Dysphagia found that bedside screening tools have sensitivity ranging from 70% to 90% for detecting aspiration risk, though specificity varies widely depending on the protocol used [4].

For patients with suspected oropharyngeal dysphagia, the SLP will typically recommend a videofluoroscopic swallowing study (VFSS), also called a modified barium swallow. This real-time X-ray study visualizes every phase of the swallow, from lip closure through upper esophageal sphincter opening. It remains the reference standard for characterizing oropharyngeal swallowing mechanics. An alternative, fiberoptic endoscopic evaluation of swallowing (FEES), uses a flexible scope passed through the nose and provides direct visualization of the larynx and hypopharynx during swallowing without radiation exposure.

Blood Work and Lab Tests Your Doctor May Order

Dysphagia itself does not have a single diagnostic blood test. Lab work serves to identify underlying systemic conditions contributing to swallowing dysfunction or to assess nutritional impact. The following panels are commonly ordered.

Complete blood count (CBC). Anemia can indicate chronic blood loss from esophageal erosions or malignancy. Iron deficiency anemia paired with dysphagia raises suspicion for Plummer-Vinson syndrome, a triad of dysphagia, iron deficiency anemia, and esophageal webs that, while rare, is associated with increased risk of squamous cell carcinoma of the pharynx and esophagus [5].

Thyroid function tests (TSH, free T4). Hypothyroidism can slow esophageal motility. A significantly enlarged thyroid gland (goiter) may also produce extrinsic compression of the esophagus. Checking TSH is standard in the workup of unexplained dysphagia, particularly when motility disorder is suspected.

Inflammatory markers (CRP, ESR). Elevated inflammatory markers may suggest autoimmune conditions affecting swallowing. Dermatomyositis and polymyositis cause proximal skeletal muscle weakness, including the striated muscles of the upper esophagus, and typically present with elevated creatine kinase alongside inflammatory markers. Systemic sclerosis (scleroderma) affects the smooth muscle of the distal esophagus in up to 90% of patients, making esophageal involvement one of the most common visceral manifestations [6].

Serum protein, albumin, and prealbumin. These assess nutritional status. Patients with long-standing dysphagia often present with protein-calorie malnutrition, and prealbumin (transthyretin) offers a more sensitive short-term marker of nutritional recovery than albumin due to its shorter half-life of approximately 2 days versus albumin's 20 days.

Autoimmune serologies. When clinical suspicion warrants it, anti-nuclear antibody (ANA), anti-Scl-70 (for scleroderma), anti-Jo-1 (for inflammatory myopathies), and acetylcholine receptor antibodies (for myasthenia gravis) may be drawn.

Upper Endoscopy: The Gold Standard for Esophageal Dysphagia

Esophagogastroduodenoscopy (EGD) is the primary diagnostic and therapeutic tool for esophageal dysphagia. The gastroenterologist passes a flexible scope through the mouth to directly visualize the esophageal mucosa, obtain tissue biopsies, and perform therapeutic interventions in the same session.

During EGD, the endoscopist looks for strictures, rings (Schatzki rings are found at the gastroesophageal junction in up to 15% of barium swallows), webs, masses, erosive esophagitis, and the characteristic furrowing or white plaques of eosinophilic esophagitis. Biopsies are taken from the proximal and distal esophagus even when the mucosa appears grossly normal, because EoE can present with a visually normal esophagus in up to 10% of cases [7].

The diagnostic yield of EGD in patients presenting with dysphagia is high. A large retrospective study published in Gastrointestinal Endoscopy found that EGD identified a clinically significant finding in 54% of patients referred for dysphagia evaluation [8]. The most common findings were peptic stricture (18%), esophageal rings (13%), erosive esophagitis (12%), and eosinophilic esophagitis (7%).

"In any patient with solid-food dysphagia, EGD with biopsies should be the initial diagnostic test," notes the American College of Gastroenterology's 2022 clinical guideline on eosinophilic esophagitis. "Biopsies should be obtained from at least two esophageal levels regardless of endoscopic appearance" [9]. This recommendation reflects the growing recognition that EoE is underdiagnosed when biopsies are skipped in normal-appearing esophagi.

Esophageal Motility Testing

When EGD is normal and biopsies show no pathology, the next step for esophageal dysphagia is high-resolution manometry (HRM). This test measures pressure along the length of the esophagus during swallows using a thin catheter with 36 pressure sensors spaced at 1 cm intervals. The resulting pressure topography plots (called Clouse plots) are interpreted according to the Chicago Classification, now in its version 4.0 published in 2021 [10].

HRM is the definitive test for achalasia, a condition in which the lower esophageal sphincter fails to relax properly and esophageal peristalsis is absent. Achalasia affects approximately 1 in 100,000 people per year. It presents with dysphagia for both solids and liquids, regurgitation of undigested food, and gradual weight loss. Three subtypes exist (type I, II, and III), and treatment response varies by subtype. Type II achalasia responds best to pneumatic dilation and Heller myotomy, with success rates exceeding 90%.

HRM also diagnoses distal esophageal spasm, jackhammer esophagus, and absent contractility. These diagnoses were previously difficult to make and frequently misclassified before high-resolution technology became widely available in the mid-2000s.

A complementary test, the timed barium esophagram (TBE), provides a simple functional assessment of esophageal emptying. The patient drinks a set volume of barium, and upright films at 1, 2, and 5 minutes quantify retained barium. It is particularly useful for monitoring treatment response in achalasia.

Eosinophilic Esophagitis: A Frequently Missed Cause

Eosinophilic esophagitis deserves special attention because it is common, increasingly recognized, and highly treatable. EoE is a chronic, immune-mediated condition defined by symptoms of esophageal dysfunction and histologic findings of 15 or more eosinophils per high-power field on esophageal biopsy. It is the leading cause of food impaction and the second most common cause of chronic dysphagia in adults after GERD [11].

Prevalence has risen sharply. Current estimates place EoE at 34.4 per 100,000 in the United States, with a male predominance of roughly 3:1. The median delay from symptom onset to diagnosis is 4 to 5 years, during which patients often unconsciously adapt by eating slowly, chewing excessively, drinking large volumes of liquid with meals, and avoiding certain food textures.

Treatment options include proton pump inhibitors (PPIs), which produce histologic remission in 33% to 50% of EoE patients, topical swallowed corticosteroids (budesonide or fluticasone), and the biologic dupilumab (Dupixent), which the FDA approved for EoE in May 2022. Dupilumab 300 mg weekly reduced the mean esophageal eosinophil count from 43.7 to 6.1 per high-power field at 24 weeks in Part A of the LIBERTY EoE TREET trial (N=81) [12]. Esophageal dilation is used for symptomatic strictures but does not address the underlying inflammation.

Common Treatable Causes and Their Workups

GERD with peptic stricture. Chronic acid reflux can produce fibrous narrowing of the distal esophagus. Patients report slowly progressive solid-food dysphagia over months to years. Diagnosis is by EGD. Treatment involves PPI therapy (omeprazole 20 to 40 mg daily or equivalent) and endoscopic dilation using bougie or balloon dilators. Most patients require one to three dilation sessions. PPI therapy should continue indefinitely to prevent stricture recurrence.

Schatzki ring. A thin mucosal ring at the gastroesophageal junction, typically presenting with intermittent solid-food dysphagia. The classic presentation involves sudden obstruction with a bolus of meat ("steakhouse syndrome"). Treatment is endoscopic dilation, and recurrence rates are approximately 30% to 40% over 2 years [13].

Esophageal cancer. Progressive dysphagia with weight loss in a patient over 50 mandates urgent EGD. Risk factors include long-standing GERD (adenocarcinoma), Barrett esophagus, tobacco use, and alcohol consumption (squamous cell carcinoma). The American Cancer Society estimates 22,370 new cases of esophageal cancer in the United States in 2024 [14]. Five-year survival for localized disease is 47%, dropping to 6% for distant-stage disease, underscoring why prompt evaluation of progressive dysphagia matters.

Medication-induced esophagitis. Bisphosphonates (alendronate), doxycycline, potassium chloride, and NSAIDs can cause direct mucosal injury. Patients present with acute odynophagia and dysphagia, often with a history of taking medications with insufficient water or immediately before lying down. Treatment involves discontinuing the offending agent, PPI therapy, and medication counseling.

Treatment Approaches by Diagnosis

Treatment depends entirely on the identified cause. No single intervention addresses "dysphagia" as a symptom in isolation. The diagnostic workup dictates the therapeutic path.

For oropharyngeal dysphagia secondary to stroke, swallowing rehabilitation with a speech-language pathologist is the primary intervention. The ESSD (European Society for Swallowing Disorders) position statement recommends early initiation of swallowing therapy within 48 hours of stroke onset when medically stable [15]. Techniques include compensatory strategies (chin tuck, head rotation), rehabilitative exercises (effortful swallow, Mendelsohn maneuver), and diet texture modification according to the International Dysphagia Diet Standardisation Initiative (IDDSI) framework.

For achalasia, three evidence-based treatments exist: pneumatic dilation, laparoscopic Heller myotomy with partial fundoplication, and peroral endoscopic myotomy (POEM). The European randomized POEM vs. laparoscopic Heller myotomy trial published in the New England Journal of Medicine (N=221) found that POEM was non-inferior to laparoscopic Heller myotomy at 2 years, with treatment success rates of 83.0% vs. 81.7% [16]. POEM has gained rapid adoption since 2015 and avoids the need for abdominal incisions.

For GERD-related dysphagia without stricture, lifestyle modifications (elevating the head of the bed, avoiding meals 3 hours before sleep, weight loss if BMI exceeds 25) combined with PPI therapy resolve symptoms in the majority of patients within 4 to 8 weeks.

When to See a Specialist

Your primary care physician can initiate the workup with history, physical examination, and basic lab work. Referral to a gastroenterologist is warranted for any of the following: solid-food dysphagia lasting longer than 2 weeks, any red-flag symptoms listed above, abnormal barium swallow, suspected motility disorder, or need for upper endoscopy. A referral to a neurologist should be considered when oropharyngeal dysphagia occurs alongside other neurological symptoms (limb weakness, tremor, vision changes, dysarthria).

For patients already using GLP-1 receptor agonists such as semaglutide or tirzepatide, new-onset dysphagia should be reported to the prescribing clinician. GLP-1 medications slow gastric emptying and may cause nausea, but true esophageal dysphagia is not an expected side effect and should not be attributed to the medication without proper evaluation.

The bottom line: a structured diagnostic algorithm starting with clinical swallowing evaluation, targeted blood work (CBC, TSH, CRP, iron studies), barium swallow or VFSS for oropharyngeal symptoms, and EGD with biopsies for esophageal symptoms identifies the cause of dysphagia in over 80% of patients and opens a clear treatment pathway for most identified conditions.